Objective: To establish the clinical utility of a new allergen-specific IgE assay (sIgE) , 3gAllergy
TM, by comparing with the established assay, ImmunoCAP
®.
Methods: Serum samples from a cohort of 93 infants with recurrent wheezing were tested for sIgE to Dermatophagoides pteronyssinus (Dp) , Japanese cedar pollen (JCP) , egg white (EW) , Milk (M) , and wheat (W) with ImmunoCAP
® and 3gAllergy systems. The samples were serially collected at study entry, 1 year, and 2 years after entry. Correlation analyses were performed for sIgE results by the two methods. Data distribution and detection performance were also analysed.
Results: Good overall correlation was observed between ImmunoCAP
® and 3gAllergy results. The Spearman's correlation coefficients for Dp, JCP, EW, M and W were 0.95, 0.94, 0.93, 0.85, 0.93, respectively. Regression analysis also showed high R square and it was considered that the 2 methods can be interchangeable. The data by 3gAllergy for Dp, JCP, and EW were higher than those by ImmunoCAP
® and wider data distribution with 3gAllergy was observed. The data for M in higher range were higher and those for W were lower than ImmunoCAP
®. Frequency of positive results with 3gAllergy tended to be higher than ImmunoCAP
®.
Conclusions: These data indicate that specific IgE levels to Dp, JCP, EW, M and W measured by the 3gAllergy and ImmunoCAP
® systems are highly correlated and can be interchangeable. Wider distribution and higher sensitivity of 3gAllergy may be useful for clinical monitoring and early diagnosis of sensitization.
View full abstract